R.E. Key et al. / Tetrahedron 75 (2019) 3118e3127
3125
minimization at each step, as implemented in Spartan ‘16. The Co-
4.5. Synthesis of asymmetric Schiff base ligands
salen moiety, cyclohexyl bridge and t-butyl groups were frozen,
while the substituents and oxygens, where appropriate, were
allowed to move. The low energy conformation for each was
refined using the M06-L density functional method, the LANL2DZ
basis set for the cobalt and the 6-31G(d,p) basis set for carbon,
nitrogen, hydrogen and oxygen. The structures were optimized,
with frequency calculations for thermal corrections and to insure
the identification of a stationary point, and done using the SMD
solvation model for ethanol. All DFT calculations were done with
Gaussian 16, Revision A.03. These data were then used to examine
possible correlations between the structure of low energy confor-
mations and the effectiveness of the catalyst. Final renderings were
carried out using Mercury 3.10 (Build 156946).
4.5.1. Synthesis of 2-((4-benzhydrylpiperazin-1-yl)methyl)-4-(tert-
butyl)-6-((E)-((((±)-trans)-2-(((E)-3,5-di-tert-butyl-2-
hydroxybenzylidene)amino)cyclohexyl)imino)methyl)phenol (22)
To a round-bottom flask equipped with a stirbar was added
(±)-trans-1,2-diaminocyclohexane (19) (1.2 mL, 9.99 mmol) and
ꢀ
anhydrous ethanol (52 mL), and the flask was cooled to 0 C. Hy-
drochloric acid (2.0 M in diethyl ether, 5 mL, 10 mmol) was added
dropwise, and the solution was stirred for 1 h at room temperature.
A
solution of 3,5-di-tert-butyl-2-hydroxybenzaldehyde (21)
(2.4079 g, 10.3 mmol) in anhydrous ethanol (52 mL) was added,
along with 4 Å MS (3.65 g). After stirring 3.25 h at room tempera-
ture, a solution of compound 17 (4.55 g, 10.3 mmol) in anhydrous
ꢀ
ethanol (172 mL þ heating at 95 C for complete dissolution) and
triethylamine (2.9 mL, 20.8 mmol) was added, and the solution was
allowed to stir for 20 h at room temperature. Upon completion, the
reaction mixture was concentrated under reduced pressure and
purified (silica gel; 2-5-10-15-20-100 EtOAc:DCM; see General In-
formation for column prep instructions). Drying under vacuum at
4
4
.4. Syntheses of catalyst precursors
.4.1. Synthesis of 3-((4-benzhydrylpiperazin-1-yl)methyl)-5-(tert-
ꢀ
butyl)-2-hydroxybenzaldehyde (17)
To a round-bottom flask equipped with a stirbar was added
potassium iodide (0.1553 g, 0.93 mmol), a solution of compound 16
65 C for 18 h gave the final product as a yellow solid in 64% yield.
ꢀ
mp: 163e166 C; R
f
¼ 0.15 (10% EtOAc:DCM); IR (neat): 2953, 2860,
2806, 2763, 1627, 1451, 1362, 1273, 1174, 1136, 1096, 1031, 1007, 911,
878, 849, 827, 773, 757, 745, 732, 705, 641 cm ; H NMR (400 MHz,
CDCl ): 13.68 (s, 1H), 13.42 (br, 1H), 8.29 (s, 1H), 8.26 (s, 1H), 7.40
ꢁ
1 1
(
(
1.98 g, 8.73 mmol) in ethyl acetate (22 mL), and a solution of 1-
diphenylmethyl)piperazine (14) (3.3410 g, 13.2 mmol) in ethyl ac-
3
d
etate (82 mL). The reaction was stirred for 1.6 h at room tempera-
ture. Upon completion, the mixture was diluted with
dichloromethane, washed with equal volumes of saturated aqueous
(d, J ¼ 8 Hz, 4H), 7.29 (d, J ¼ 4 Hz, 1H), 7.27e7.22 (m, 5H), 7.15 (m,
J ¼ 8 Hz, 2H), 7.02 (d, J ¼ 4 Hz, 1H), 6.97 (d, J ¼ 4 Hz, 1H), 4.21 (s, 1H),
3.61 (d, J ¼ 12 Hz, 1H), 3.49 (d, J ¼ 12 Hz, 1H), 3.36e3.22 (m, 2H),
2.52 (br, 4H), 2.43 (br, 4H), 1.97e1.81 (m, 4H), 1.77e1.64 (m, 2H),
NaHCO
under reduced pressure. Purification (silica gel; 0-2-5-10-100%
EtOAc:DCM) gave 17 as an off-white solid in 43% yield. R
¼ 0.62
10% EtOAc:DCM); IR (neat) 2963, 2806, 2762, 1677, 1605, 1479,
3 2 4
(2X), dried over anhydrous Na SO , and concentrated
13
1.50e1.42 (m, 2H), 1.40 (s, 9H), 1.23 (s, 9H), 1.20 (s, 9H); C NMR:
(100 MHz, CDCl ): 165.7, 165.1, 158.0, 157.2, 143.0, 140.4, 139.9,
f
3
d
(
136.3, 128.4, 128.0, 126.77, 126.7, 126.65, 126.0, 124.4, 76.4, 72.8,
1
6
451, 1281, 1236, 1216, 1133, 1004, 971, 896, 850, 758, 744, 708, 693,
72.2, 56.3, 54.0, 52.0, 34.9, 34.0, 33.8, 33.4, 33.1, 31.43, 31.35, 29.4,
ꢁ
1
1
þ
05 cm
;
H NMR (400 MHz, CDCl
3
):
d
10.29 (s, 1H), 7.62 (d,
24.3; DART-TOF Calcd for C50
755.52542.
H
66
N
4
O
2
(M þ H) : 755.5264; found
J ¼ 4 Hz, 1H), 7.42e7.38 (m, 4H), 7.29e7.24 (m, 5H), 7.20e7.15 (m,
13
2
H), 4.27 (s, 1H), 3.78 (s, 2H), 2.76e2.39 (br, 8H), 1.29 (s, 9H);
C
NMR (100 MHz, CDCl
3
):
d
192.0, 159.2, 142.3, 141.8, 133.1, 128.5,
4.5.2. Synthesis of 2,4-di-tert-butyl-6-((E)-((((±)-trans)-2-(((E)-5-
(tert-butyl)-2-hydroxy-3-((4-phenethylpiperazin-1-yl)methyl)
benzylidene)amino)cyclohexyl)imino)methyl)phenol (23)
127.8, 127.0, 124.9, 122.5, 121.9, 75.9, 59.6, 52.8, 51.4, 34.0, 31.2;
þ
DART-TOF Calcd for C29
H
34
N
2
O
2
(M þ H) : 443.26985, found
4
43.26883.
To a round-bottom flask equipped with a stirbar was added
compound 19 (0.35 mL, 2.91 mmol) and anhydrous ethanol (15 mL),
ꢀ
and the flask was cooled to 0 C. Hydrochloric acid (2.0 M in diethyl
ether, 1.5 mL, 3.0 mmol) was added dropwise, and the solution was
stirred for 1 h at room temperature. A solution of compound 21
(0.6758 g, 2.88 mmol) in anhydrous ethanol (15 mL) was added.
After stirring 2.5 h at room temperature, a solution of compound 18
(1.1035 g, 2.90 mmol) in anhydrous ethanol (98 mL and then heated
4
.4.2. Synthesis of 5-(tert-butyl)-2-hydroxy-3-((4-
phenethylpiperazin-1-yl)methyl)benzaldehyde (18)
To a round-bottom flask equipped with a stirbar was added
potassium iodide (0.3712 g, 2.24 mmol), a solution of compound 16
ꢀ
(
5.02 g, 22.1 mmol) in ethyl acetate (56 mL), and a solution of 1-
phenethylpiperazine (15) (6.3 mL, 33.3 mmol) in ethyl acetate
56 mL). The reaction was stirred for 1.5 h at room temperature.
at 80 C to fully dissolve the salicylaldehyde) and triethylamine
(0.82 mL, 5.88 mmol) was added, and the solution was stirred for
21 h at room temperature. Upon completion, the reaction mixture
was concentrated under reduced pressure and purified (silica gel;
5-10-20-40-50-100% EtOAc:hexanes). Drying under vacuum at
(
Upon completion, the mixture was diluted with an equal volume of
dichloromethane, washed with equal volumes of saturated aqueous
ꢀ
NaHCO
methane (1X), dried over anhydrous Na
under reduced pressure. Purification (silica gel; 0-5-20-25-100%
EtOAc:DCM) gave 18 as an off-white solid in 30% yield. R
¼ 0.31,
20% EtOAc:hexanes); IR (neat) 2948, 2847, 2803, 2847, 2762, 1673,
3
(2X), back extracted with an equal volume of dichloro-
65 C for 5 h gave the final product as a solid in 60% yield. mp:
ꢀ
2
SO , and concentrated
4
102e104 C; R
f
¼ 0.18 (40% EtOAc:hexanes); IR (neat): 2950, 2862,
2808, 1627, 1456, 1362, 1272, 1173, 1133, 1095, 1034, 1012, 908, 878,
818, 772, 731, 699, 644 cm
ꢁ
1 1
f
; H NMR (400 MHz, CDCl ): d 13.70
3
(
(br, 1H), 13.44 (br, 1H), 8.31 (s, 1H), 8.27 (s, 1H), 7.33 (d, J ¼ 4 Hz, 1H),
7.31 (d, J ¼ 4 Hz, 1H), 7.30e7.25 (m, 2H), 7.21e7.16 (m, 3H), 7.05 (d,
J ¼ 4 Hz, 1H), 6.99 (d, J ¼ 4 Hz, 1H), 3.64 (d, J ¼ 16 Hz, 1H), 3.54 (d,
J ¼ 16 Hz, 1H), 3.39e3.23 (m, 2H), 2.83e2.76 (m, 2H), 2.62e2.54 (m,
1
8
1
7
8
604, 1474, 1363, 1292, 1220, 1154, 1132, 1114, 1006, 962, 930, 888,
ꢁ
1 1
46, 819, 754, 701, 605 cm ; H NMR (400 MHz, CDCl
H), 7.64 (d, J ¼ 2.4 Hz, 1H), 7.33 (d, J ¼ 4 Hz, 1H), 7.31e7.27 (m, 2H),
.22e7.18 (m, 3H), 3.75 (s, 2H), 2.84e2.77 (m, 4H), 2.68e2.59 (m,
H), 1.30 (s, 9H); 13C NMR (100 MHz, CDCl
): 191.8, 159.2, 141.9,
3
): d 10.34 (s,
10H), 1.98e1.82 (m, 4H), 1.79e1.64 (m, 2H), 1.51e1.42 (m, 2H), 1.41
13
3
d
(s, 9H), 1.24 (s, 9H), 1.23 (s, 9H); C NMR (100 MHz, CDCl
3
):
d
165.7,
1
5
40.1, 132.9, 128.7, 128.4, 126.1, 124.8, 122.8, 122.1, 60.2, 59.9, 52.9,
165.1, 158.0, 157.3, 140.5, 140.4, 140.0, 136.4, 130.7, 128.7, 128.3,
126.7, 126.0, 125.97, 117.84, 117.80, 72.8, 72.3, 60.6, 56.3, 53.2, 53.1,
35.0, 34.1, 33.8, 33.7, 33.4, 33.1, 31.44, 31.37, 29.4, 24.33, 24.27;
þ
2.6, 34.1, 33.6, 31.3; DART-TOF Calcd for C24
32
H N
2
O
2
(M þ H) :
3
81.2542; found 381.25444.